AbbVie
ABBV
#29
Rank
HK$2.375 T
Marketcap
HK$1,343
Share price
0.76%
Change (1 day)
4.41%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.57. In 2022 the company made an earnings per share (EPS) of HK$51.68 an increase over its 2021 EPS that were of HK$50.35.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.25%
2022HK$51.682.63%
2021HK$50.35125.21%
2020HK$22.36-45.69%
2019HK$41.1748.35%
2018HK$27.757.6%
2017HK$25.79-9.3%
2016HK$28.4415.48%
2015HK$24.62185.53%
2014HK$8.62-57.11%
2013HK$20.11-21.69%
2012HK$25.6855.73%
2011HK$16.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.44-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.82 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.14 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.84 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.08 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.29 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.17-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.41-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.21-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA